Summary: To predict CYP4A-mediated reactions, we developed a two-dimensional template scoring system based on published data. The system predicts the order of occurrence among multiple oxidation sites, as well as the regioselectivity. The template has a linearly arranged honeycomb shape and an adjacent area. Molecules are overlaid on the template with the locations of the atoms restricted to the corners of hexagonal blocks. The overlaid conformers are then checked to determine whether they reside within the template area, and their position occupancy and position function scores are calculated. The position occupancy score is determined based on occupation of the respective positions on the template. The functional and steric properties are reflected in the position function score. The sum of these scores is compared among possible conformers, and the conformer with the highest total score is predicted to be preferentially metabolized. In the present study, prediction of sites of CYP4A-mediated oxidation and classification into substrates and non-substrates were performed for collected compounds, and agreement between predicted and experimental data exceeded 95% for substrates and non-substrates. The template scoring system can be easily linked to databases of two-dimensional chemical structures, and thus this system may be useful for drug development and studies of drug metabolism.
Introduction
Cytochrome P450 4A ¤CYP4A¥ enzymes selectively catalyze Ý-hydroxylation of fatty acids such as lauric acid.
1,2¥
The selectivity of CYP4A for Ý-hydroxylation is particularly striking since the electron density of the C-H bonds is much lower at the Ý-terminal methyl group than the adjacent Ý%1 methylene group. 3¥ CYP4A enzymes are also involved in the metabolism of physiologically important lipid components such as eicosanoids, prostaglandins and arachidonic acid 4®6¥ and also of drugs such as febuxostat. 7¥ Therefore, prediction of CYP4A-mediated metabolism is important at the discovery stage of new drug development.
Methods for prediction of CYP metabolism have used ligand-property-based approaches such as quantitative structure-activity relationships ¤QSAR¥ or X-ray crystallography-based docking. However, the prediction of multiple sites of oxidation of a substrate is not well handled in most cases, and classification of molecules as substrates and nonsubstrates is also difficult. These studies show that current approaches are not sufficiently developed for exact prediction of the regioselectivity of substrate biotransformation. This is partly because of the conformational flexibility of CYP enzymes, including adaptive changes of the enzyme conformation and multiple binding sites. A clear advantage of studying human P450 enzymes compared with other enzymes is the ample experimental data for specific recombinant forms. In addition, data consistency is now established between human-derived preparations and recombinant forms. These data may allow mapping of the active sites of CYP isoforms from substrate structures only.
Substrates are often oxidized at multiple sites at varying rates by a single CYP isoform. Thus, a substrate may interact with a CYP isoform in multiple conformations.
Current docking models show the three-dimensional interactions of a CYP isoform with a substrate in a certain conformation, but these data are not readily comparable for multiple conformations of a substrate. In the present study, a two-dimensional template and scoring system was developed to examine the regioselectivity of CYP4A-mediated reactions based on published data.
Materials and Methods
Experimental data for CYP4A recombinant enzymes were obtained from the literature. If the sites of oxidation of a substrate were unknown, the data were excluded. Most data were from assays using the human CYP4A11 recombinant enzyme. Some data derived from rat CYP4A1 recombinant and purified enzymes were also used to compensate for information missing for the human enzyme. Data from CYP4A1/NADPH-P450 reductase-fusion protein or liver microsomes were used if only these were available for a particular substrate. According to the experimental data, the substrate concentration did not affect the priority of reactions for the substrate. Thus, substrate concentration was not considered in this study. Data for a total of 108 compounds ¤52 substrates, 45 non-substrates and 11 inhibitors¥ were used.
1,2,4,5,7®63¥ These compounds are listed in Table 1 .
ISIS/Draw ver. 2.5 ¤MDL Information Systems, San Leandro, CA¥ was used to generate secondary structures of the compounds and to examine the suitability of specific conformers as a substrate. Substrates with rigid structures were used for generation of the initial template through overlays. Typical substrates of CYP4A enzymes such as lauric acid have a flexible structure and are not easily used for mapping of the CYP4A binding site. Arranging the carbonyl group and possible sites of oxidation in substrates in specific regions gave a template that could be used to approximate the allowable ligand shape and size. Scores were counted manually for all possible conformers. For verification of a compound as a CYP4A substrate, atoms of the substrate were first fitted to a corner of the template ¤for example, to the site of oxidation¥ and then oriented so that the atoms matched the corners of the hexagons in the template while staying within the border. Inverted structures were also evaluated in this way.
A conformer was judged to be a candidate substrate if all parts of the structure remained within the border of the template. Position occupancy and position function scores were calculated for different conformers to predict the order of reactions. Hydrogen atoms on substrates were not included. In compounds with rings other than six-membered rings, each atom on the ring was associated with the nearest corner on the template.
Results
General CYP4A-ligand interactions: Most CYP4A substrates have a carboxyl group at the opposite end of the 
Prostaglandin A1 ¤4¥
Oleic acid ¤8¥
Linoleic acid ¤8¥
All-trans-retinoic acid ¤12¥
13-cis-Retinoic acid ¤13¥
Phytanic acid ¤14¥
Z9¤10¥-EpSTA ¤15¥
Luciferin-ME ¤16¥
Luciferin-CEE ¤16¥
Luciferin-4A ¤17¥
Luciferin-MultiCYP ¤17¥
Febuxostat ¤7¥
U44069 ¤18¥

U51605 ¤18¥
Leukotriene B4 ¤15¥
5,8,11-Eicosatrienoic acid ¤5¥
Eicosapentaenoic acid ¤5¥
Docosahexaenoic acid ¤5¥
Farnesol ¤19¥
7-¤p-Tolyloxy¥heptanoic acid ¤10¥
7-¤m-Tolyloxy¥heptanoic acid ¤10¥
m-¤n-Heptyloxy¥-benzoic acid ¤10¥
p-¤n-Heptyloxy¥-benzoic acid ¤10¥
4$-Methoxy-4-biphenylcarboxylic acid ¤10¥
11,11-Dimethyllauric acid ¤10¥
11-Dodecenoic acid ¤20¥
11-Dodecynoic acid ¤20¥
Methyl laurate ¤2¥
Lauryl alcohol ¤2¥
2,2-Dimethyllauric acid ¤2¥
trans-2-Dodecenoic acid ¤2¥ Dodecane ¤2¥
10-Methoxydecanoic acid ¤2,21¥
12-Chlorododecanoic acid ¤22¥
12-Bromododecanoic acid ¤22¥
Continued on next page:
molecule from the oxidation site ¤Table 1¥. CYP4A enzymes metabolize carboxylic acid esters such as methyl laurate and Luciferin-MultiCYP and alkylamides including lauramide diethanolamine; 2,17,24,25¥ these enzymes are inhibited by N-hydroxyformamidines ¤HET0016 and TS-011¥ and acylsulfonamide ¤N-methylsulfonyl-15,15-dibromopentadec-14-enamide¥.
55,59,62¥ Thus, a charge-pair interaction between the carboxylate anion and a positively charged group on the enzyme is unlikely to be required for ligand recognition of CYP4A. Instead, dipole interactions and hydrogen bonding between sites on CYP4A ¤referred to as trigger sites¥ and a carbonyl group or homologous polar moiety of the substrate were assumed to be the initial requirements for a molecule to be a substrate. CYP4A enzymes also metabolize lauryl alcohol, 2¥ and thus hydrogen bond donors as well as hydrogen bond acceptors ¤e.g. methyl ester¥ may be able to interact with the CYP4A trigger site.
Allowable ligand size: The template was generated through overlays of substrates with rigid structures. Movement of atoms was restricted and the atoms were assumed to sit only on the corners of the honeycomb structure. This approach yielded a template with a linearly arranged honeycomb structure and an adjacent area ¤Fig. 1¥. The rings in the template were defined as Rings A to G. To prevent confusion with naming of template rings and substrate/ligand rings, a capital letter is used for the template ring. Location numbers ¤from 1 to 29¥ were assigned to the corner of each ring to identify modes of interaction.
Continued:
Compounds References 12-Iodododecanoic acid ¤22¥
10-Methylthiodecanoic acid ¤21¥
8,9-Epoxyeicosatrienoic acid ¤23¥
11,12-Epoxyeicosatrienoic acid ¤23¥
14,15-Epoxyeicosatrienoic acid ¤23¥
Lauramide diethanolamine ¤24,25¥
Non-substrates Valsartan ¤26¥
Quinacrine ¤47¥
NE-100 ¤48¥
Arecoline ¤49¥
Indiplon
¤50¥
Resveratrol ¤51¥
CP-122,721 ¤52¥
Imatinib ¤53¥
Stearic acid ¤8¥
3-Hydroxystearic acid ¤9¥
Prostaglandin E1 ¤4¥
9-cis-Retinoic acid ¤13¥
Luciferin-BE ¤16¥
Luciferin-H ¤17¥
Luciferin-ME-EGE ¤16¥
Lauramide ¤2¥
6-¤2-Propargyloxyphenyl¥-hexanoic acid ¤54,55¥
N-Methanesulfonyl-6-¤2-proparglyoxyphenyl¥-hexanamide ¤55¥
Continued on next column:
Continued:
Compounds References Endosulfan ¤57¥
4-Ipomeanol ¤56¥
m-¤n-Amyloxy¥hydrocinnamic acid ¤10¥
p-¤n-Amyloxy¥hydrocinnamic acid ¤10¥
9-Phenylnonanoic acid ¤10,20¥
8-Phenyloctanoic acid ¤10¥
Inhibitors 17-Octadecynoic acid ¤58¥
1-Aminobenzotriazole ¤61¥
TS-011 ¤62¥
Sesamin ¤63¥
Naproxen
¤10¥
Ibuprofen ¤10¥
Cimetidine ¤10¥ 10-Imidazolyldecanoic acid ¤10,20¥
11,12-Methanolauric acid ¤2¥
N-Methylsulfonyl-15,15-dibromopentadec-14-enamide ¤54,55¥
The template scoring system was developed using data for the 34 underlined compounds
Template Scoring System to Predict CYP4A-mediated ReactionsCYP4A11 catalyzes Ý-hydroxylation of prostaglandin A1, but not of its 11-hydroxyl derivative, prostaglandin E1.
4¥
The hydroxyl group of prostaglandin E1 was located at position 26 on the template ¤Fig. 2A¥. These data suggest that CYP4A substrates cannot enter position 26 of Ring D.
Prostaglandin A1 may arrange its carboxylic acid chain on Ring F and an adjacent area ¤Ring G¥ of the template ¤Fig. 2B¥. The limitation at position 26 of Ring D was consisted with luciferin-ME ¤Fig. 2C¥.
CYP4A isoforms were assumed to recognize substrates at a trigger site present on Ring F, and to oxidize them at the bottom of Ring A or B ¤positions 1 to 3¥. For example, alltrans retinoic acid ¤Fig. 3A¥ and 13-cis retinoic acid ¤Fig. 3B¥ were placed within the template, whereas no conformations of 9-cis retinoic acid ¤Fig. 3D¥ could be fitted within the template, since the cyclohexenyl group extended beyond the boundary of the template. These results are consistent with experimental data 12,13¥ and suggest the validity of this template for an initial classification of compounds into substrates and non-substrates.
Oxidation site: CYP4A11 mediates selective 4-hydroxylation of 13-cis retinoic acid ¤Fig. 3B¥. Thus, position 1 on the template was assumed to be a site of oxidation. For all-trans retinoic acid, 18-hydroxylation is the primary reaction, followed by 4-hydroxylation and 5,6-epoxidation ¤Fig. 3A¥. Based on the simulated interactions of both compounds, positions 1, 2 and 3 were judged to be sites of oxidation, with position 3 preferred over positions 1 and 2.
Overlays of caproic acid showed that position 2 becomes the only site of oxidation for Ý-hydroxylation under conditions without occupancy of positions 1 and 3 ¤Figs. 4A and 4B¥. Ý-Hydroxylation at position 2 may also occur with occupancy of position 1 ¤Figs. 4C to 4F¥. Other placements ¤Figs. 4G to 4J¥ suggested Ý-hydroxylation at position 1. As shown in Figure 1 , placement at positions 7 and 8 on the template were suggested for CYP4A11 substrates. These results suggest that CYP4A11-mediated oxidation of caproic acid occurs as shown in Figures 4A or 4B . The predicted result is consistent with experimental data showing that CYP4A11 oxidizes caproic acid selectively to the Ý-hydroxy metabolite.
1¥
CYP4A11 also oxidizes Ý-regions of fatty acids with 11 to 20 carbon atoms. For example, CYP4A11 oxidizes lauric acid primarily at the terminal ¤Ý¥ site rather than the energetically favorable Ý%1 site. This phenomenon can be explained if the terminal region of lauric acid occupies positions 2, 7 and 8 of the template, and this supports the idea of positions 1 to 3 as sites of oxidation ¤Figs. 5A to 5D¥.
The structures of m-¤n-heptyloxy¥benzoic acid and m-¤n-amyloxy¥hydrocinnamic acid closely resemble each other, except for the location of the phenylene unit. However, CYP4A1 mediates Ý-hydroxylation of the former, but not of the latter.
10¥ m-¤n-Heptyloxy¥benzoic acid can be placed on the template at positions 2, 7 and 8 ¤Fig. 6A¥. The terminal residue of m-¤n-amyloxy¥hydrocinnamic acid can reach the site of oxidation through positions 9 and 29 to fulfill the need for Ring F triggering by the carboxylic acid moiety ¤Fig. 6B¥, but not through positions 7 and 8 ¤Fig. 6C¥. These results further support a regional requirement of positions 2, 7 and 8 for oxidation.
The overlays of these substrates on the template suggest a mutual occupancy of a region located from positions 7 to 13 of Rings B to D, which are shown in bold on the template ¤Fig. 1¥. This region of CYP4A1 may hold alkyl chains through hydrophobic interactions. Trigger site: The carboxyl group of CYP4A substrates was arranged on Ring F on the template. All-trans retinoic acid can fit on the template only in the conformation shown in Figure 3A . Thus, positions 19®20 were judged to be a trigger site for interaction with the carbonyl carbon-oxygen. CYP4A11 mainly mediates 18-hydroxylation and, to lesser extents, 4-hydroxylation and 5,6-epoxidation. 12¥ In contrast, this enzyme rather selectively catalyzes 4-hydroxylation for 13-cis retinoic acid. 13¥ These differences in regioselectivity suggest the possibility of a shift of the trigger site to positions 21®22 for 13-cis retinoic acid ¤Fig. 3B¥. Placement of the carbonyl moiety of 13-cis retinoic acid at positions 23®22 allowed overlay of the trimethylcyclohexene moiety on Ring A ¤Fig. 3C¥. This interaction is likely to generate the 18-hydroxy derivative as well as the 4-hydroxy derivative, but CYP4A11 selectively mediates 4-hydroxylation of 13-cis retinoic acid. These results suggest reduced trigger capacity for interaction at positions 23®22. Similarly, overlays of p-¤n-heptyloxy¥benzoic acid and prostaglandin A1 for Ý-hydroxylation suggest that positions 22®21 and 22®23 accept trigger interactions ¤Figs. 6D and 2B¥. CYP4A11 mediates Ý-oxidation and slight Ý%1 oxidation of caproic acid. The predicted placement of caproic acid on the template is shown in Figures 4A and 4B . These interactions suggest triggering by the carbonyl group of caproic acid at positions 15 and 23 or 15 and 19. Thus, collectively the results suggest trigger roles for all positions on Ring F ¤positions 15, 19, 20, 21, 22 and 23¥. Scoring system for the CYP4A template: The template with Rings A to G was generated using typical substrates for CYP4A11 and CYP4A1. Simulated interactions suggested a contribution of multiple conformers of CYP4A substrates to metabolite formation, but did not address the priority of these conformers. To predict the preference of interactions among these conformers, a scoring system was devised. In this system, the highest score among the possible interactions is taken to indicate the primary metabolite. The total score is obtained as the sum of the position occupancy score and the position function score. Position occupancy reflects the distribution of atoms at the corners of the template. Position function is used to compensate for the limitations of a two-dimensional model by introducing physicochemical information for residues at specific positions. Both scores have distinct values that depend on the contribution of the simulated interaction.
Both caproic acid ¤C10¥ and lauric acid ¤C12¥ are preferentially oxidized regioselectively at the Ý-carbon and to lesser extents at the Ý%1 position. 1¥ To reproduce these experimental results, positions 7, 8, 9 and 10 were scored as 3 points and position 2 as 5 points to reflect the hydrophobic interaction with the terminal carbon. Other positions thought to interact with ligands were scored as 1 point. The position occupancy points are shown using coloring of the position number in Figure 1 ¤5 in red, 3 in blue, 1 in black and 0 in gray¥. The position function points are described below and summarized in Table 2 .
18-Hydroxylation is the preferential reaction for all-trans retinoic acid, followed by 4-hydroxylation and 5,6-epoxidation. To reflect this regioselectivity, %2 and %1 points were assigned to positions 2 and 3, respectively, when a molecule occupies position 1 and/or 3.
Affinities of the trigger interaction may also vary among the positions. Thus, to improve the fit between experimental and simulated results, positions 23®22, 15®19, 15®23, 21® 20 and 22®23 were assigned %2 points ¤see Affinity of trigger site and regioselectivity of saturated fatty acids¥.
Steric properties at specific positions on the template: To compensate for the relatively limited chemical information in a two-dimensional model, position function points were introduced to reflect steric and chemical properties. Positions 4 and 5 of Ring A are expected to accept a cyclohexene ring based on the simulated interaction of all-trans retinoic acid ¤Fig. 3A¥. CYP4A11 metabolizes luciferin-ME, while this enzyme only slightly oxidizes luciferin-CEE 16¥ ¤Fig. 7¥. Positions 4 and 5 of Ring A were thus assumed to have limited depth and flexibility for accepting flexible residues such as a chloroethyl group. Similarly, the terminal alkyl chain of pentadecanoic acid and palmitoic acid ¤C15 and C16 saturated straightchain fatty acids¥ were not expected to fit into positions 4 and 5 of Ring A. Thus, overlay of a terminal alkyl chain at positions 4 and 5 of the template was scored as %2 points. This scoring system reflects the experimental preferences for oxidation sites of fatty acids ¤see Affinity of trigger site and regioselectivity of fatty acids¥.
CYP4A11 oxidizes the prostaglandin analogs U44069 and U51605 to their Ý-hydroxy metabolites 18¥ ¤Figs. 8A and 8B¥. Ring E was thus assumed to have a certain level of depth. CYP4A enzymes also catalyze Ý-hydroxylation of 11,11-dimethyllaurate 10¥ ¤Fig. 8C¥. This is consistent with the idea that positions 6 and 7 of Ring A have space to accept bulky residues. In contrast, CYP4A only slightly metabolizes 2,2-dimethyllaurate 2¥ ¤Fig. 8D¥, suggesting that position 15 is likely to accept planar groups only.
Affinity of trigger site and regioselectivity of saturated fatty acids: Fourteen simulated interactions that gave the highest score among all possible conformers of lauric acid are shown with their scores on the template in Figure 5 . These interactions for Ý-hydroxylation ¤Figs. 5A to 5I¥ and ¤Ý%1¥-hydroxylation ¤Figs. 5J to 5M¥ gave the highest scores of 24. Experimental data suggest preferential Ý-hydroxylation of this fatty acid. 1¥ To explain the difference, trigger interactions of the carbonyl group at positions 15®19 and 15®23 ¤Figs. 5E, 5J, 5K, 5L and 5M¥ were assumed to have lower affinities compared with those at positions 19®20, 20®21 and 22®21 ¤Figs. 5A to 5D¥. As shown for 13-cis retinoic acid, trigger interactions at positions 23®22 ¤Figs. 5F and 5G¥ also had lower affinities. Thus, %2 points were assigned to trigger interactions at 1¥ reported regioselectivities of saturated straight-chain fatty acids of various lengths ¤C10 to C16¥ using recombinant human CYP4A11 enzyme. Caproic acid, undecanoic acid and lauric acid ¤C10 to C12¥ are metabolized selectively by CYP4A11 at the Ý-carbon ¤Ý/¤Ý%1¥ ratios of 15 to 17¥, whereas tridecanoic acid, myristic acid, pentadecanoic acid and palmitoic acid ¤C13 to C16¥ have reduced selectivity ¤Ý/¤Ý%1¥ ratios of 2 to 3¥. Simulated interactions with fatty acids suggested %2 points for the position function for trigger interactions at positions 21®20 and 22®23. To verify this choice, simulated results obtained using the scoring system were compared with experimental data ¤Table 3¥.
Caproic acid, undecanoic acid and lauric acid exhibited higher scores for Ý-hydroxylation ¤scores of 20, 23 and 24, respectively¥ than for ¤Ý%1¥-hydroxylation ¤scores of 16, 19 and 22, respectively¥. These results are consistent with experimental data for CYP4A11. Tridecanoic acid, myristic acid, pentadecanoic acid and palmitoic acid, which showed reduced selectivities, had equivalent highest scores for Ý-and ¤Ý®1¥-hydroxylation. CYP4A1 oxidizes 12-chloro-, 12-bromo-and 12-iodododecanoic acids to 12-hydroxydodecanoic acid ¤Ý-oxidation¥ and 12-oxododecanoic acid ª¤Ý%1¥-oxidation«.
22¥ The alcohol is hypothesized to arise from oxidation of the halide to an oxohalonium species that is hydrolyzed by water, whereas the aldehyde arises by a conventional carbon hydroxylation-elimination mechanism.
22¥ 12-Chloro-and 12-bromododecanoic acids are oxidized preferentially at the Ý%1 position over the Ý position ¤oxidation of halogen¥. To account for these phenomena, %2 points were assigned to a halogen atom located at the oxidation site ¤positions 1 to 3 of the template, Figs. 9A to 9F¥. For 12-iodododecanoic acid, the Ý-and ¤Ý%1¥-oxidations occur to similar extents, suggesting that iodine is too large to enter position 29 on the template. Thus, %2 points were also given for this interaction ¤Fig. 9I¥.
CYP4A1 oxidizes 10-methylthiodecanoic acid primarily at the Ý%1 site, whereas 10-methoxydecanoic acid undergoes Ý-oxidation. 21¥ These results are explained by the greater length of the C-S bond ¤1.81 !¥ relative to the C-C ¤1.54 !¥ or C-O ¤1.41 !¥ bond and by the greater atomic radius and polarizability of the S atom vs. O or CH 2 , which places the reactive lone pair of electrons on the S atom close enough to the oxoiron ferryl group that they become the energetically favored target. Thus, ¦2 points were given for a sulfur atom at position 2.
Steric configuration of Ring A or Ring B relative to the heme plane: CYP4A1 Ý-hydroxylates both 7-¤p-tolyloxy¥heptanoic acid and 7-¤m-tolyloxy¥heptanoic acid at their benzylic methyl group, but not at their aromatic ring.
10¥ CYP4A1 does not oxidize 8-phenyloctanoic acid or 9-phenylnonanoic acid, but these molecules strongly inhibit lauric acid oxidation. 10¥ The latter observation suggests that these compounds enter the active site of CYP4A1 and interfere with lauric acidös access to the active site. In these interactions, the phenyl ring may be lying in a plane that is perpendicular to the heme plane. Thus, the C-H bonds on the edge of the phenyl ring, rather than the p-orbitals of the aromatic system, are oriented toward the heme ferryl group. In this arrangement, the ferryl group is not able to attack the Ô-electron system, which is the typical pathway leading to aromatic hydroxylation by CYP enzymes.
64,65¥
Aromatic C-H bonds are very much stronger than aliphatic C-H bonds, and therefore the aromatic ring is not a substrate for CYP4A1. These ideas are consistent with the steric configuration of oxidation sites for CYP4A1 proposed by Bambal and Hanzlik.
10¥
As shown in Figures 10C and 10D , overlays of 8-phenyloctanoic acid and 9-phenylnonanoic acid on the template allowed the phenyl rings to sit on Ring A or Ring B. Therefore, Rings A and B were assumed to be located in a plane perpendicular to the heme plane.
Application of the template to compounds with condensed rings or biphenyl groups: CYP4A isoforms also oxidize condensed-ring or biphenyl compounds such as luciferin derivatives, febuxostat and 4$-methoxy-4-biphenylcarboxylic acid.
7,10,16,17¥ Simulated interactions of these compounds are shown in Figures 7 and 11 . These substrates could not be overlaid perfectly on the template, but did not exceed the allowable size or location. Parts of the structures sat over the central portion of Ring D, but not position 26, where the substrate is not accepted. Luciferin-BE is unlikely to interact with CYP4A because the benzyl group crossed the boundary of the template. The ethylene glycol of luciferin-ME-EGE also crossed the boundary at Ring G. Luciferin-H was too short to reach the oxidation site of the template.
Verification of the template scoring system: The template scoring system was developed using data for the 34 compounds shown underlined in Table 1 ¤29 substrates and 5 non-substrates¥. All the predicted results for these compounds were consistent with experimental results. Data for 23 substrates and 40 non-substrates were not used for template construction, and these were applied to verify the accuracy of the template. As shown in Table 4 , the template approach predicted the site of oxidation in 22 of the 23 substrates found experimentally to undergo CYP4A-mediated oxidation, while 39 of the 40 non-substrates could not be fitted to the template and were predicted to be non-substrates. Thus, agreement between predicted and experimental data exceeded 95% for substrates and nonsubstrates.
Possible inhibitory interactions: Possible interactions of inhibitors of CYP4A-mediated oxidation are shown in Figure 12 . Naproxen ¤Fig. 12A¥ and ibuprofen ¤Fig. 12B¥, which inhibit lauric acid hydroxylation, 10¥ have a carboxylic acid residue that is recognized at the trigger site. Thus, these structures bind to CYP4A1, but are too short to reach the oxidation site of the template. HET0016 ¤Fig. 12C¥ and TS-011 ¤Fig. 12D¥, which are potent CYP4A inhibitors, 59,62¥ were also too short to reach the oxidation site. These two compounds have N-hydroxyformamidine groups, and this moiety may interact at the trigger site with an affinity greater than those of carboxyl and carbonyl groups. 11,12-Methanolauric acid, a cyclopropane fatty acid, inhibits lauric acid hydroxylation.
2¥
This compound could fit onto the template, but with the cyclopropyl moiety at position 6 ¤Fig. 12F¥, rather than position 2 ¤Fig. 12E¥. Only a flat structure coplanar with the alkyl backbone is allowed to enter close to the heme in the area of Ring A. 
Discussion
In this study, we developed a two-dimensional template to identify a ligand as a CYP4A substrate. Distinct roles of CYP4A regions were assumed for triggering, interaction and oxidation based on different positions on the template. Our results suggest a primary role for a trigger site to promote a CYP4A-mediated reaction. Thus, CYP4A substrates may change conformation to interact with the CYP4A active site after triggering. Alternatively, CYP4A isoforms may anchor substrates through an initial interaction around Ring F, with a subsequent change in enzyme conformation to open up other parts of the active site. In the template, substrates are anchored through interactions at positions 7 to 13. Oxidation is accomplished if the interaction allows placement of an atom at the oxidized site ¤positions 1 to 3¥.
The template also allows prediction of the priority of regioselective reactions based on a scoring system. The total score is the sum of the position occupancy score and the position function score on the template. The highest total score was used to define the primary reaction. Several substrates are oxidized at multiple sites by CYP4A, and the predicted orders of reactions were largely consistent with experimental data for CYP4A-mediated reactions, including for flexible substrates such as saturated straight-chain fatty acids. Experimentally reported sites of CYP4A-mediated oxidation were predicted for 51 of 52 substrates. Previous studies of fatty acid derivatives have suggested that activity requires a certain distance between the carboxylic acid and terminal moiety. In the template, the properties of these regions were defined as stereochemical and positional requirements. Our results suggest that an intermediate area ¤Rings B, C and D on the template¥ is also essential for the CYP4A-substrate interaction.
In this study, we used data that were mostly obtained with human CYP4A11 recombinant enzyme, but some data from rat CYP4A1 were also included. Dierks et al. 61¥ found differences in the susceptibility of these two CYP4A enzymes to inhibition by substituted imidazoles. These results suggest that the human CYP4A11 oxidation site is somewhat different from that of rat CYP4A1. However, we did not find a marked difference in the order of reaction at multiple oxidation sites or in the regioselectivity of substrates. Moreover, the template scoring system predicted experimentally reported sites for CYP4A11-mediated oxidation for almost all substrates. Thus, it appears that the active sites of CYP4A11 and CYP4A1 resemble each other in terms of the properties considered in development of the template.
Two molecules showed inconsistency between the predicted and experimental results. Lauramide should recognize the trigger site of CYP4A because it can both donate and accept hydrogen bonds. However, it is not a substrate for CYP4A and does not inhibit hydroxylation of lauric acid. 2¥ Second, dodecane does not have polar moieties to interact with the trigger site, but CYP4A slowly oxidizes this compound to lauryl alcohol. 2¥ The reasons for these discrepancies are unclear, but they suggest that more work is needed to improve the template and scoring system. Within this limitation, the template developed in the study is a versatile tool for studying CYP-mediated metabolism. This approach is likely to be useful for drug design and development, since the template can be easily applied to databases of secondary structures.
